Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Assets: 2021-2025

Historic Non-Current Assets for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $202,000.

  • Roivant Sciences' Non-Current Assets rose 36.07% to $551.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $551.0 million, marking a year-over-year increase of 36.07%. This contributed to the annual value of $202,000 for FY2025, which is 98.60% down from last year.
  • Per Roivant Sciences' latest filing, its Non-Current Assets stood at $202,000 for FY2025, which was down 99.95% from $428.4 million recorded in FY2024.
  • Over the past 5 years, Roivant Sciences' Non-Current Assets peaked at $591.0 million during FY2023, and registered a low of $202,000 during FY2025.
  • Moreover, its 3-year median value for Non-Current Assets was $428.4 million (2024), whereas its average is $308.0 million.
  • As far as peak fluctuations go, Roivant Sciences' Non-Current Assets soared by 34.75% in 2023, and later slumped by 98.60% in 2025.
  • Over the past 5 years, Roivant Sciences' Non-Current Assets (Yearly) stood at $402.7 million in 2021, then reached $511.8 million in 2021, then rose by 8.92% to $438.6 million in 2022, then climbed by 8.77% to $556.7 million in 2022, then soared by 34.75% to $591.0 million in 2023, then dropped by 9.12% to $505.9 million in 2023, then plummeted by 97.56% to $14.4 million in 2024, then decreased by 15.33% to $428.4 million in 2024, then slumped by 98.60% to $202,000 in 2025.